RT Journal Article
SR Electronic
T1 The COVID-19 infection in Italy: a statistical study of an abnormally severe disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.28.20046243
DO 10.1101/2020.03.28.20046243
A1 Giuseppe, De Natale
A1 Ricciardi, Valerio
A1 De Luca, Gabriele
A1 De Natale, Dario
A1 Di Meglio, Giovanni
A1 Ferragamo, Antonio
A1 Marchitelli, Vito
A1 Piccolo, Andrea
A1 Scala, Antonio
A1 Somma, Renato
A1 Spina, Emanuele
A1 Troise, Claudia
YR 2020
UL http://medrxiv.org/content/early/2020/04/01/2020.03.28.20046243.abstract
AB We statistically investigate the COVID-19 epidemics, which is particularly invasive in Italy. We show that the high apparent mortality (or Case Fatality Ratio, CFR) observed in Italy, as compared with other countries, is likely biased by a strong underestimation of infected cases. To give a more realistic estimate of the mortality of Covid-19, we use the most recent estimates of the IFR (Infection Fatality Ratio) of epidemic, based on CFR for Germany, and furthermore analyse data obtained from the ship ‘Diamond Princess’, a good representation of a ‘laboratory’ case-study from an isolated system in which all the people have been tested. From such analyses we try to derive more realistic estimates of the real extension of the infection, as well as more accurate indicators of how fast the infection propagates. We then try to point out, from the various explanations proposed, the dominant factors causing such an abnormal seriousness of the disease in Italy. Finally, we use the deceased data, the only ones estimated to be reliable enough, to predict the total number of infected people and the interval of time when the infection in Italy could stop.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo supporting fundsAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data are taken by public datasets, referenced in the paper. They are free to be used for anyone.